Publications | Page 3 | Cervo Brain Research Centre

Export 13 results:

Filters: Author is Soucy, Geneviève [Clear All Filters]

2020

S. Pozzi, Codron, P., Soucy, G., Renaud, L., Cordeau, P., Dutta, K., Bareil, C., and J-P Julien, “Monoclonal full-length antibody against TAR DNA-binding protein 43 reduces related proteinopathy in neurons.”, JCI Insight, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid”, Acta neuropathologica communications, vol. 8, no. 1, pp. 65 - 65, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid.”, Acta Neuropathol Commun, vol. 8, no. 1, p. 65, 2020.

2019

S. Pozzi, Thammisetty, S. Sampath, Codron, P., Rahimian, R., Plourde, K. Valérie, Soucy, G., Bareil, C., Phaneuf, D., Kriz, J., Gravel, C., and J-P Julien, “Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology.”, J Clin Invest, vol. 129, no. 4, pp. 1581-1595, 2019.

2016

Y. Iguchi, Eid, L., Parent, M., Soucy, G., Bareil, C., Riku, Y., Kawai, K., Takagi, S., Yoshida, M., Katsuno, M., Sobue, G., and J-P Julien, “Exosome secretion is a key pathway for clearance of pathological TDP-43.”, Brain, vol. 139, no. Pt 12, pp. 3187-3201, 2016.

M. Gravel, Béland, L. - C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., and Kriz, J., “IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.”, J Neurosci, vol. 36, no. 3, pp. 1031-48, 2016.

Y. Ohta, Soucy, G., Phaneuf, D., Audet, J. - N., Gros-Louis, F., Rouleau, G. A., Blasco, H., Corcia, P., Andersen, P. M., Nordin, F., Yamashita, T., Abe, K., and J-P Julien, “Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.”, Hum Mol Genet, 2016.

Y. Ohta, Soucy, G., Phaneuf, D., Audet, J. - N., Gros-Louis, F., Rouleau, G. A., Blasco, H., Corcia, P., Andersen, P. M., Nordin, F., Yamashita, T., Abe, K., and J-P Julien, “Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.”, Hum Mol Genet, vol. 25, no. 21, pp. 4771-4786, 2016.

2014

P. Patel, Kriz, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., and J-P Julien, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.

S. L. Roche, Sherman, D. L., Dissanayake, K., Soucy, G., Desmazieres, A., Lamont, D. J., Peles, E., J-P Julien, Wishart, T. M., Ribchester, R. R., Brophy, P. J., and Gillingwater, T. H., “Loss of glial neurofascin155 delays developmental synapse elimination at the neuromuscular junction.”, J Neurosci, vol. 34, no. 38, pp. 12904-18, 2014.

2012

J. - N. Audet, Gowing, G., Paradis, R., Soucy, G., and J-P Julien, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.

2010

F. Gros-Louis, Soucy, G., Larivière, R., and J-P Julien, “Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.”, J Neurochem, vol. 113, no. 5, pp. 1188-99, 2010.

2006

G. Gowing, Dequen, F., Soucy, G., and J-P Julien, “Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations.”, J Neurosci, vol. 26, no. 44, pp. 11397-402, 2006.

Funding / Support / Partners

© Gouvernement du Québec